Renal Safety and Renin–Angiotensin–Aldosterone System Inhibitors in Patients With Contrast Media Exposure: A Multicenter Randomized Controlled Study

There is no clear consensus on the safety of renin–angiotensin–aldosterone system inhibitors in patients with contrast media exposure. We aimed to assess the safety of renin–angiotensin–aldosterone system inhibitors in patients exposed to contrast media at 1-year follow-up. Patients treated with ang...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yaowang, Dong, Shaohong, Liu, Yuanhui, Wang, Yongshun, Sun, Xin, Yuan, Jie, Yu, Danqing, Liu, Huadong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640273/
https://www.ncbi.nlm.nih.gov/pubmed/35881908
http://dx.doi.org/10.1097/FJC.0000000000001325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640273/
https://www.ncbi.nlm.nih.gov/pubmed/35881908
http://dx.doi.org/10.1097/FJC.0000000000001325

Ejemplares similares